Correll CU - Search Results

1

What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Correll CU, Rubio JM, Kane JM. Correll CU, et al. World Psychiatry. 2018 Jun;17(2):149-160. doi: 10.1002/wps.20516. World Psychiatry. 2018. PMID: 29856543 Free PMC article.

2

Early prediction of antipsychotic response in schizophrenia.

Correll CU, Malhotra AK, Kaushik S, McMeniman M, Kane JM. Correll CU, et al. Am J Psychiatry. 2003 Nov;160(11):2063-5. doi: 10.1176/appi.ajp.160.11.2063. Am J Psychiatry. 2003. PMID: 14594760

3

Treatment models and designs for intervention research during the psychotic prodrome.

Kane JM, Krystal J, Correll CU. Kane JM, et al. Among authors: correll cu. Schizophr Bull. 2003;29(4):747-56. doi: 10.1093/oxfordjournals.schbul.a007044. Schizophr Bull. 2003. PMID: 14989412 Review.

4

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.

Correll CU, Leucht S, Kane JM. Correll CU, et al. Am J Psychiatry. 2004 Mar;161(3):414-25. doi: 10.1176/appi.ajp.161.3.414. Am J Psychiatry. 2004. PMID: 14992963 Review.

5

Metabolic effects of treatment with atypical antipsychotics.

Kane JM, Barrett EJ, Casey DE, Correll CU, Gelenberg AJ, Klein S, Newcomer JW. Kane JM, et al. Among authors: correll cu. J Clin Psychiatry. 2004 Nov;65(11):1447-55. doi: 10.4088/jcp.v65n1102. J Clin Psychiatry. 2004. PMID: 15554755 Free article. No abstract available.

6

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.

Straker D, Correll CU, Kramer-Ginsberg E, Abdulhamid N, Koshy F, Rubens E, Saint-Vil R, Kane JM, Manu P. Straker D, et al. Among authors: correll cu. Am J Psychiatry. 2005 Jun;162(6):1217-21. doi: 10.1176/appi.ajp.162.6.1217. Am J Psychiatry. 2005. PMID: 15930076

7

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

Correll CU, Frederickson AM, Kane JM, Manu P. Correll CU, et al. J Clin Psychiatry. 2006 Apr;67(4):575-83. doi: 10.4088/jcp.v67n0408. J Clin Psychiatry. 2006. PMID: 16669722

8

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

Correll CU, Frederickson AM, Kane JM, Manu P. Correll CU, et al. Schizophr Res. 2007 Jan;89(1-3):91-100. doi: 10.1016/j.schres.2006.08.017. Epub 2006 Oct 27. Schizophr Res. 2007. PMID: 17070017 Free PMC article.

9

Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities.

Correll CU, Harris JL, Pantaleon Moya RA, Frederickson AM, Kane JM, Manu P. Correll CU, et al. Schizophr Res. 2007 May;92(1-3):103-7. doi: 10.1016/j.schres.2007.01.004. Epub 2007 Mar 6. Schizophr Res. 2007. PMID: 17337161

10

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents.

Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU. Cornblatt BA, et al. Among authors: correll cu. J Clin Psychiatry. 2007 Apr;68(4):546-57. doi: 10.4088/jcp.v68n0410. J Clin Psychiatry. 2007. PMID: 17474810 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

921 results

Search Page

Filters